Upper gastrointestinal Crohn's disease: What are we talking about?
2024

Upper gastrointestinal Crohn's disease: What are we talking about?

Editorial

Author Information

Author(s): Bertin Luisa, Barberio Brigida, Savarino Edoardo Vincenzo

Primary Institution: Azienda Ospedale Università Padova

Conclusion

The diagnosis and management of upper gastrointestinal Crohn's disease are challenging due to limited evidence and the heterogeneous nature of the disease.

Supporting Evidence

  • Upper gastrointestinal Crohn's disease is increasingly recognized despite being less common.
  • 41% of newly diagnosed adult Crohn's disease patients had upper gastrointestinal involvement, but only 32% showed symptoms.
  • The definition of upper gastrointestinal Crohn's disease varies across studies, complicating diagnosis.
  • Histological findings in the absence of symptoms complicate management strategies.

Takeaway

Upper gastrointestinal Crohn's disease is hard to diagnose and treat because it doesn't show clear symptoms and there's not enough research on it.

Limitations

There is a lack of standardized definitions and limited data on the treatment of upper gastrointestinal Crohn's disease.

Digital Object Identifier (DOI)

10.1002/ueg2.12664

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication